Sign in
4

Changes in Ownership

Contineum Therapeutics, Inc. Filed Acc 0001437749-26-004126

CEO and President sold 400 shares at $16.00 ($6,400)

  • CEO and President acquired 400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Stengone Carmine N. · CEO and President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-11 Exercise or conversion : show line 1 in the form 10b5-1 +400 $1.26 $504 15,354 D
2026-02-11 Sale : show line 2 in the form 10b5-1 −400 $16.00 $6,400 14,954 D
Open-market sales · 400 sh · avg $16.00 · $6,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-11 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −400 128,017 D
Loading xslF345X05/rdgdoc.xml…